STOCK WARRANTS (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 19, 2023 |
Jan. 24, 2023 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
|
Issuance and sale of shares | 901,275 | ||||||
Offering price | $ 8.00 | ||||||
Warrant exercise price per share | 13.60 | ||||||
Warrant exercise price decreased | $ 8.00 | ||||||
Deemed dividend | $ 164 | $ 164 | |||||
Iroquois and Other Investor [Member] | |||||||
Stock issued to settle litigation | 183,486 | ||||||
Warrant [Member] | |||||||
Outstanding warrants, intrinsic value | |||||||
Number of warrants cancelled | 32,974 | ||||||
Warrant [Member] | Iroquois and Other Investor [Member] | |||||||
Number of warrants cancelled | 32,140 |
X | ||||||||||
- Definition Deemed dividend due to warrant reset. No definition available.
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non option aggregate intrinsic value non vested. No definition available.
|
X | ||||||||||
- Definition Stock issued during period shares to settle litigation. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|